Abstract
We describe the results of the Spanish Coalition to Unlock Research on Host Genetics on COVID-19 (SCOURGE). In sex-disaggregated genome-wide studies of COVID-19 hospitalization, we found two known loci associated among males (SLC6A20-LZTFL1 and IFNAR2), and a novel one among females (TLE1). Meta-analyses with independent studies revealed two novel associations (AQP3 and ARHGAP33) and replicated ELF5. A genetic risk score predicted COVID-19 severity, especially among younger males. We found less SNP-heritability and larger heritability differences by age (<60/≥60 years) among males than females. Inbreeding depression was associated with COVID-19 hospitalization and severity, and the effect was stronger among older males.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study has been funded by Instituto de Salud Carlos III (COV20_00622 to A.C., COV20/00792 to M.B, COV20_00181 to J.M.A.G., COV20_1144 to M.A.J.S., PI20/00876 to C.F) and cofunded by European Union (ERDF) "A way of making Europe". Fundacion Amancio Ortega, Banco de Santander (to A.C), Estrella de Levante S.A. and Colabora Mujer Association (to EG-N) and Obra Social La Caixa (to R.B); Agencia Estatal de Investigacion (RTC-2017-6471-1 to C.F), Cabildo Insular de Tenerife (CGIEU0000219140 "Apuestas cientificas del ITER para colaborar en la lucha contra la COVID-19" to C.F., have also contributed to its funding. R.L-R is granted by Catedra de Medicina Genomica IIS-Fundacion Jimenez Diaz-UAM, M.B. by Nextgeneration EU funds. M.C., P.M., M.A.J.S., A.F.R. are granted by the Miguel Servet Programme (CP17/00006, CP16/00116, CPII20CIII/0001, CPII20CIII/0001 respectively) and B.A. by the Juan Rodes Programme (JR17/00020), all of them from Instituto de Salud Carlos III, and cofunded by European Union (ERDF) "A way of making Europe".
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The whole project (discovery SCOURGE cohort) was approved by the Galician Ethical Committee Ref 2020/197. Replication samples (CNIO cohort) were recruited under the ethical committee approval CEI PI 34_2020-v2.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
Summary statistics of this study will be aggregated with those from the COVID-19 Host Genetics Initiative (https://www.covid19hg.org); data will also be shared upon request to the corresponding authors.
